MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,077 | +1167.1% | 24,720 | +1224.8% | 0.47% | +715.5% |
| Q4 2022 | $85 | -100.0% | 1,866 | -48.3% | 0.06% | -78.3% |
| Q1 2022 | $296,000 | +218.3% | 3,612 | +542.7% | 0.27% | +184.0% |
| Q3 2020 | $93,000 | -89.4% | 562 | -93.4% | 0.09% | -71.8% |
| Q2 2020 | $881,000 | 0.0% | 8,554 | 0.0% | 0.33% | -33.0% |
| Q2 2019 | $881,000 | – | 8,554 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |